These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12174732)

  • 1. Assessing full remission.
    McIntyre R; Kennedy S; Bagby RM; Bakish D
    J Psychiatry Neurosci; 2002 Jul; 27(4):235-9. PubMed ID: 12174732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the relationship between functional impairment/recovery and depression severity: a pooled analysis.
    Guico-Pabia CJ; Fayyad RS; Soares CN
    Int Clin Psychopharmacol; 2012 Jan; 27(1):1-7. PubMed ID: 21971533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional impairment in patients with major depression in clinical remission: results from the VIVAL-D-Rem, a nationwide, naturalistic, cross-sectional survey.
    Sacchetti E; Frank E; Siracusano A; Racagni G; Vita A; Turrina C
    Int Clin Psychopharmacol; 2015 May; 30(3):129-41. PubMed ID: 25828864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validation analysis of two self-reported HAM-D6 versions.
    Bech P; Wilson P; Wessel T; Lunde M; Fava M
    Acta Psychiatr Scand; 2009 Apr; 119(4):298-303. PubMed ID: 19032701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Validity of the Different Versions of the Hamilton Depression Scale in Separating Remission Rates of Placebo and Antidepressants in Clinical Trials of Major Depression.
    Kyle PR; Lemming OM; Timmerby N; Søndergaard S; Andreasson K; Bech P
    J Clin Psychopharmacol; 2016 Oct; 36(5):453-6. PubMed ID: 27525966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and reliability of the HAM-D/MADRS interview: an integrated depression symptom rating scale.
    Iannuzzo RW; Jaeger J; Goldberg JF; Kafantaris V; Sublette ME
    Psychiatry Res; 2006 Nov; 145(1):21-37. PubMed ID: 17049379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HAM-D17 and HAM-D6 sensitivity to change in relation to desvenlafaxine dose and baseline depression severity in major depressive disorder.
    Bech P; Boyer P; Germain JM; Padmanabhan K; Haudiquet V; Pitrosky B; Tourian KA
    Pharmacopsychiatry; 2010 Nov; 43(7):271-6. PubMed ID: 20830664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of alexithymic features on response to antidepressant medication in patients with major depression.
    Ozsahin A; Uzun O; Cansever A; Gulcat Z
    Depress Anxiety; 2003; 18(2):62-6. PubMed ID: 12964172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity among depressed outpatients considered to be in remission.
    Zimmerman M; Posternak MA; Chelminski I
    Compr Psychiatry; 2007; 48(2):113-7. PubMed ID: 17292700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cut-off points of the Depression and Somatic Symptoms Scale and the Hospital Anxiety and Depression Scale in detecting non-full remission and a current major depressive episode.
    Hung CI; Liu CY; Wang SJ; Yao YC; Yang CH
    Int J Psychiatry Clin Pract; 2012 Mar; 16(1):33-40. PubMed ID: 22122659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.
    Mannel M; Kuhn U; Schmidt U; Ploch M; Murck H
    J Psychiatr Res; 2010 Sep; 44(12):760-7. PubMed ID: 20181361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trial.
    Dunlop BW; Parikh SV; Rothschild AJ; Thase ME; DeBattista C; Conway CR; Forester BP; Mondimore FM; Shelton RC; Macaluso M; Logan J; Traxler P; Li J; Johnson H; Greden JF
    BMC Psychiatry; 2019 Dec; 19(1):420. PubMed ID: 31881956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining remission from depression on two self-report symptom scales: a comparison of the Quick Inventory of Depressive Symptomatology and the Clinically Useful Depression Outcome Scale.
    Zimmerman M; Martinez J; Attiullah N; Friedman M; Toba C; Boerescu DA; Rahgeb M
    Compr Psychiatry; 2012 Oct; 53(7):1034-8. PubMed ID: 22520091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis by age and sex of efficacy data from placebo-controlled trials of desvenlafaxine in outpatients with major depressive disorder.
    Kornstein SG; Clayton AH; Soares CN; Padmanabhan SK; Guico-Pabia CJ
    J Clin Psychopharmacol; 2010 Jun; 30(3):294-9. PubMed ID: 20473066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression.
    Hsiao CC
    Psychoneuroendocrinology; 2006 Aug; 31(7):839-46. PubMed ID: 16716529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric evaluation of a 6-item Chinese version of the Hamilton Depression Rating Scale: Mokken scaling and item analysis.
    Lee CP; Liu CY; Hung CI
    Asia Pac Psychiatry; 2017 Sep; 9(3):. PubMed ID: 28585368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.